March 25, 2025 - 16:47

Health insurers are rapidly integrating artificial intelligence (AI) tools into their operations, significantly transforming the landscape of healthcare management. While these advancements promise enhanced efficiency and improved patient outcomes, the swift adoption of AI technologies has outpaced the ability of regulators to monitor their impact adequately.
The lack of transparency surrounding AI applications in health insurance raises critical questions about patient safety and care quality. Insurers are employing AI for various purposes, including claims processing, risk assessment, and personalized treatment recommendations. However, the algorithms driving these decisions often operate as "black boxes," making it challenging for both patients and healthcare providers to understand how decisions are made.
As the industry continues to embrace AI, experts urge for increased regulatory scrutiny and guidelines to ensure that these technologies are used ethically and transparently. Without proper oversight, there is a risk that patients may not receive the fair treatment and care they deserve, highlighting the urgent need for a balance between innovation and accountability in the healthcare sector.
July 18, 2026 - 01:20
State of the Lake presentation discusses Tahoe’s health in a warming worldTAHOE CITY, Calif. - Fifty years ago this July, Tahoe Environmental Research Center founder Charles R. Goldman launched the John Le Conte onto Lake Tahoe. That vessel is still in use today, marking...
July 17, 2026 - 09:59
MDCalc is scoring the clinical calculators used by millions of doctorsMDCalc, a widely used online platform for medical reference, is rolling out a new quality-rating system for its library of over 800 clinical calculators. These tools help physicians assess...
July 16, 2026 - 22:30
Long Sleep Hours Linked to Higher Alzheimer's Protein Levels, UT Health San Antonio Study FindsA new study from UT Health San Antonio has uncovered a concerning connection between sleeping long hours and increased levels of a protein associated with Alzheimer`s disease. Researchers found...
July 16, 2026 - 04:31
University of Michigan’s David C. Miller chosen to succeed Jeff Balser as Vanderbilt Health’s President and CEO and Dean of Vanderbilt University School of MedicineDavid C. Miller, MD, MPH, has been selected as the next President and Chief Executive Officer of Vanderbilt Health and Dean of the Vanderbilt University School of Medicine. Miller currently serves...